Category - New Drugs
FDA Approves The ACTpen for Actemra, A Single-Dose, Prefilled Autoinjector
FDA Approves Daurismo (glasdegib) for Patients with Acute Myeloid Leukemia
Genentech Announces FDA Grants Venclexta Accelerated Approval for People With Newly-Diagnosed Acute Myeloid Leukemia or Those Who Are Ineligible For Intensive Induction Chemotherapy
FDA Approves Gamifant (emapalumab-lzsg) for Primary Hemophagocytic Lymphohistiocytosis
FDA Approves Aemcolo (rifamycin) to Treat Travelers’ Diarrhea
FDA Approves Adcetris (brentuximab vedotin) in Combination with Chemotherapy for Adults with Previously Untreated Systemic Anaplastic Large Cell Lymphoma or Other CD30-Expressing Peripheral T-Cell Lymphomas
FDA Approves Promacta (eltrombopag) for First-Line Severe Aplastic Anemia
FDA Approves Yupelri (revefenacin) for Chronic Obstructive Pulmonary Disease (COPD)